Nov 11, 2025,
News,
Nov 06, 2025
Bitcoin’s (CRYPTO: BTC) drop to the $100,000 mark signals fading demand and steady long-term holder (LTH) selling, according to a new report. What Happened: The market remains oversold but not capitulated, with defensive risk sentiment across spot, ETF, and derivatives…
News
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan raised Qorvo, Inc. (NASDAQ:QRVO) price target from $92…
Nov 04, 2025
Keep reading
Ad
If you can’t decide whether to get the 2-in-1 Windows tablet hybrid, traditional laptop, or desktop, we’re here to help.
News
Pfizer Inc. (NYSE:PFE) will release earnings results for the third quarter before the opening bell on Tuesday, Nov. 4. Analysts expect the health care company to report quarterly earnings at 64 cents per share, down from $1.06 per share in…
Nov 03, 2025
Keep reading
News
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst…
Oct 31, 2025
Keep reading
Ad
If you can’t decide whether to get the 2-in-1 Windows tablet hybrid, traditional laptop, or desktop, we’re here to help.
Are You Taking One of These 9 “Memory Erasing” Prescriptions? [ad]
You may think your memory loss is just a sign of getting older, but one of these 9 drugs could actually be damaging your brain... These 9 prescription drugs have now been linked to Alzheimer's disease diagnoses. If you're over the age of 60, and you're taking even 1 of these 9 drugs, your brain could be at risk. Click here to learn more.